Oorsprong van het eerstegraads netwerk van Heather L. Davis
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA
24
| Subsidiary | Pharmaceuticals: Major | 24 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Heather L. Davis via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO President | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| QIAGEN N.V. | Medical Specialties | Chairman Founder | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GELESIS INC | Biotechnology | Director/Board Member | |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Operating Officer | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| MYREXIS, INC. | Financial Conglomerates | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Director/Board Member | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Masters Business Admin | |
| Princeton University | College/University | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of Iowa | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Bristol | College/University | Graduate Degree | |
| Universität zu Köln | College/University | Doctorate Degree Doctorate Degree | |
| University of Vienna | College/University | Corporate Officer/Principal | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Astra Pharmaceutical Products, Inc. | General Counsel General Counsel | ||
| The University of Law Ltd. | College/University | Graduate Degree | |
Caris Life Sciences, LLC
 Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Enpharma Ltd.
 Enpharma Ltd. Pharmaceuticals: MajorHealth Technology Enpharma Ltd. operates as a pharmaceutical firm. The company was founded by Joachim Schorr on February 04, 2000 and is headquartered in Eynsham, the United Kingdom. | Pharmaceuticals: Major | Founder | |
| VERASTEM, INC. | Biotechnology | Chief Executive Officer | |
Rhapsody Biologics, Inc.
 Rhapsody Biologics, Inc. BiotechnologyHealth Technology Rhapsody Biologics, Inc. develops a personalized peptide vaccine platform. It predicts and optimizes peptide vaccines for use at an individual and population level. Its platform technology encompasses a discovery system to identify immunogenic fragments of disease causing agents that will stimulate an immune response. The company was founded by Richard Paul Kivel and Ren Ee Chee in October 2009 and is headquartered in Norwell, MA. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
SevenOaks Biosystems LLC
 SevenOaks Biosystems LLC Medical SpecialtiesHealth Technology Part of Medline Industries LP (Illinois), SevenOaks Biosystems LLC is a company that develops medical devices. The company is based in Cambridge, MA. The company was founded by Richard Rox Anderson, Sameer A. Sabir. SevenOaks Biosystems was acquired by Medline Industries LP (Illinois) on November 30, 2016. | Medical Specialties | Director/Board Member | |
| CHECKMATE PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Founder | |
Pillar Biosciences, Inc.
 Pillar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pillar Biosciences, Inc. is a clinical cancer diagnostics company. The firm engages in the creation of precision NGS panels and software solutions. It offers solid tumor panels, blood cancer panels, inherited disease panels, and custom panels. The company was founded by Gang Song and Zhaohui Wang in 2014 and is headquartered in Natick, MA. | Pharmaceuticals: Major | Director/Board Member | |
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member | |
APIS Assay Technologies Ltd.
 APIS Assay Technologies Ltd. BiotechnologyHealth Technology APIS Assay Technologies Ltd. engages in clinical potential of systems biology in the diagnosis of treatment. The company is headquartered in Manchester, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Deciduous Therapeutics, Inc.
 Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
Brixton Biosciences, Inc.
 Brixton Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Brixton Biosciences, Inc. has developed coolio™ therapy, an injection that provides long-lasting pain relief as an alternative to opioids. The company is based in Cambridge, MA and was founded by Robert M. Forrester and Sameer A. Sabir. The therapy is designed to desensitize pain in a targeted area and has the potential to eradicate the pain of pain. | Miscellaneous Commercial Services | Founder | |
| EQRX, INC. | Pharmaceuticals: Major | Founder | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Verenigd Koninkrijk | 7 |
| Canada | 3 |
| Nederland | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 157 |
| Corporate Officer/Principal | 69 |
| Independent Dir/Board Member | 39 |
| Chairman | 25 |
| Founder | 20 |
Sterkste connecties
| Insiders | |
|---|---|
| Anthony Evnin | 46 |
| James Edward Thomas | 26 |
| Robert M. Forrester | 25 |
| Robert Hugin | 24 |
| Patrick J. Langlois | 23 |
| Ken Bate | 19 |
| Robert Cawthorn | 17 |
| Deanna M. Petersen | 14 |
| Justin Renz | 12 |
| Barbara H. Deptula | 12 |
| Christian Schetter | 12 |
| Susan T. Hager | 11 |
| Ferdinand E. Massari | 10 |
| Robert L. Bratzler | 10 |
| Arthur M. Krieg | 10 |
- Beurs
- Insiders
- Heather L. Davis
- Bedrijfsconnecties
